Long-Term Outcome and its Predictors Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by Shock. Insights From the GUSTO-I Trial

Journal of the American College of Cardiology

Volumn 50, Issue 18, 2007, Pages 1752-1758

  Singh, Mandeep ^a   White, Jennifer ^b   Hasdai, David ^c   Hodgson, Patricia K ^b   Berger, Peter B ^d   Topol, Eric J ^e   Califf, Robert M ^b   Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c RABIN MEDICAL CENTER   (Israel)

^d GEISINGER MEDICAL CENTER   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART RATE; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SMOKING; ST SEGMENT ELEVATION; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SHOCK, CARDIOGENIC; SURVIVAL RATE; TIME FACTORS;

EID: 35348990181     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.04.101     Document Type: Article

References (23)

1. Berger P.B., Tuttle R.H., Holmes Jr. D.R., et al. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. Circulation 99 (1999) 873-878
2. Chen E.W., Canto J.G., Parsons L.S., et al. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation 108 (2003) 951-957
3. Dzavik V., Sleeper L.A., Cocke T.P., et al. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK trial registry. Eur Heart J 24 (2003) 828-837
4. Hasdai D., Holmes Jr. D.R., Califf R.M., et al., GUSTO Investigators. Cardiogenic shock complicating acute myocardial infarction: predictors of death. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. Am Heart J 138 (1999) 21-31
5. Hasdai D., Topol E.J., Califf R.M., Berger P.B., and Holmes Jr. D.R. Cardiogenic shock complicating acute coronary syndromes. Lancet 356 (2000) 749-756
6. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107 (2003) 2998-3002
7. Hochman J.S., Sleeper L.A., White H.D., et al. One-year survival following early revascularization for cardiogenic shock. JAMA 285 (2001) 190-192
8. Lee L., Erbel R., Brown T.M., Laufer N., Meyer J., and O'Neill W.W. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol 17 (1991) 599-603
9. Tedesco J.V., Williams B.A., Wright R.S., et al. Baseline comorbidities and treatment strategy in elderly patients are associated with outcome of cardiogenic shock in a community-based population. Am Heart J 146 (2003) 472-478
10. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
11. Stone C.J., and Koo C.Y. Additive splines in statistics. Proc Stat Comp Sect Am Statist Assoc (1985) 45-48
12. Altman D.G., and Andersen P.K. Bootstrap investigation of the stability of a Cox regression model. Stat Med 8 (1988) 771-783
13. Sauerbrei W., and Shumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 11 (1992) 2093-2109
14. Baigent C., Collins R., Appleby P., Parish S., Sleight P., Peto R., and The ISIS-2 (Second International Study of Infarct Survival) collaborative group. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 316 (1998) 1337-1343
15. Franzosi M.G., Santoro E., De Vita C., et al. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. Circulation 98 (1998) 2659-2665
16. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295 (2006) 2511-2515
17. Lindholm M.G., Kober L., Boesgaard S., Torp-Pedersen C., Aldershvile J., and TRACE Study Group. Cardiogenic shock complicating acute myocardial infarction: prognostic impact of early and late shock development. Eur Heart J 24 (2003) 258-265
18. Bowers T.R., Terrien E.F., O'Neill W.W., Sachs D., and Grines C.L. Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy). PAMI Investigators. Am J Cardiol 78 (1996) 511-515
19. Hasdai D., Lerman A., Rihal C.S., et al. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J 137 (1999) 612-620
20. Jacobs A.K., French J.K., Col J., et al. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?. J Am Coll Cardiol 36 (2000) 1091-1096
21. Holmes Jr. D.R., Berger P.B., Hochman J.S., et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 100 (1999) 2067-2073
22. Mukherjee D., Fang J., Chetcuti S., Moscucci M., Kline-Rogers E., and Eagle K.A. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 109 (2004) 745-749
23. Antman E.M. New guidelines for ST elevation myocardial infarction. Timely Top Med Cardiovasc Dis 8 (2004) E11